(Phe1-(R)-Gly2)-Nociceptin (1-13) amide
CAS No. ———
(Phe1-(R)-Gly2)-Nociceptin (1-13) amide( ——— )
Catalog No. M40051 CAS No. ———
(Phe1-(R)-Gly2)-Nociceptin (1-13) amide
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name(Phe1-(R)-Gly2)-Nociceptin (1-13) amide
-
NoteResearch use only, not for human use.
-
Brief Description(Phe1-(R)-Gly2)-Nociceptin (1-13) amide
-
Description(Phe1-(R)-Gly2)-Nociceptin (1-13) amide
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight———
-
Molecular Formula———
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Octenyl succinic anh...
Octenyl succinic anhydride (OSA) is utilized to esterify starch, producing octenyl succinylated starch (OS-starch), a hydrocolloid with amphiphilic properties.
-
GLP-2 (rat)
GLP-2(rat) is an intestinal growth factor. GLP-2(rat) stimulates cell proliferation and inhibits apoptosis. GLP-2(rat) enhances mucosal mass and function in residual small intestine after massive small bowel resection (MSBR).
-
Burosumab
Burosumab(KRN23) is a human monoclonal antibody targeting fibroblast growth factor 23 (FGF23) for the treatment of cutaneous-skeletal hypophosphatemic syndrome (CSHS) and tumor-induced osteochondrosis.
Cart
sales@molnova.com